Roth Capital Affirms Bioblast Pharma (ORPN) at 'Buy'; Sees Trehalose PK Data as 'Meaningful' Oct 24, 2016 11:50AM
Roth Capital Affirms Bioblast Pharma (ORPN) at 'Buy'; Extension Study Data Shows Sustainable Improvements Sep 12, 2016 12:43PM
Roth Capital Affirms BioBlast Pharma (ORPN) at 'Buy'; Sees Trehalose Plan Heading in Right Direction Aug 25, 2016 11:13AM
Roth Capital Trims PT on BioBlast (ORPN) to $15; New Focus is Tough, But Necessary, Decision Jun 9, 2016 09:06AM
BioBlast Pharma (ORPN) Prices Common Stock, Warrants Direct Offering for Proceeds of $6.7M Mar 17, 2016 07:03AM


Mar 17, 2016 07:00AM BioBlast Pharma Announces Pricing of $6.7 Million Registered Direct Offering
Dec 9, 2015 10:57AM Roth Believes BioBlast (ORPN) Management Made Prudent Decision with Cabaletta Phase 2b
Nov 17, 2015 09:00AM Roth Capital Bullish on Recent BioBlast Pharma (ORPN) Hires; Reaffirms at 'Buy'
Aug 21, 2015 10:32AM Roth Capital Positive on BioBlast Pharma (ORPN) Following Q2 Report; H215 Should be Busy with Phase 3 Initiations
Jun 15, 2015 10:27AM Bio Blast Pharma (ORPN) PT Raised to $25 at Roth Capital
May 19, 2015 11:10AM Roth Affirms BioBlast Pharma (ORPN) at 'Buy' Following Q1 Report; U.S. Phase II/III HOPEMD Enrollment Remains Next Milestone
Apr 9, 2015 10:29AM BioBlast Pharma's (ORPN) Cabaletta Fast Track Designation Viewed as Incremental Positive by Roth Capital; 'Buy' Rating Affirmed
Mar 5, 2015 08:00AM BioBlast Pharma to Present at the 27th Annual ROTH Investor Conference
Feb 25, 2015 11:40AM Upcoming Milestones, Key Investment Points for Bio Blast Pharma (ORPN) Being Missed by Investors - Roth Capital
Feb 17, 2015 12:11PM Roth Affirms Bio Blast Pharma (ORPN) at 'Buy'; Plenty of Catalysts Ahead in Next 12 - 18 Months
Feb 2, 2015 02:43PM Roth Capital Positive on BioBlast Pharma (ORPN) CEO Appointment; Affirms at 'Buy'
Aug 25, 2014 08:37AM UPDATE: Roth Capital Starts Bio Blast Pharma (ORPN) at Buy
Jul 31, 2014 10:33AM Bio Blast Pharma (ORPN) IPO Opens, Trades Lower